Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Skrit37on Sep 05, 2020 2:46pm
274 Views
Post# 31515698

RE:RE:RE:RE:RE:Innovative risk management Est. 1992

RE:RE:RE:RE:RE:Innovative risk management Est. 1992
Nailbiter1 wrote:
gpe2005 wrote: I'm sorry, but I'm having a hard time connecting the dots. Why would we pick this particular company to expand access to Aristotle across the US? Are we talking about the one location company on Canal Street in New Orleans?

DYODD Buddy.
Look at the news releases and search Mercer.
Once you have seen the size of Mercer, you'll need a spare pair of pants to change into.
IRMS is just added to the pile. 


Cant wait until q3...hopefully we will get another update on how mercer is more and more involved...they will be a huge factor to my early retirement haha Any new connections Mercer give szls for covid is basically the trial run for eventual Aristotle release to them Well planned and executed...just need a bit more patience for sustained revenue to begin Goodluck folks
Bullboard Posts